The Albanese Government has effectively rejected or obfuscated most of the committee's recommendations, but that does not mean the response has no value or cannot contribute to positive change. Stakeholders must understand the nuance and recognise the real opportunities because these processes never deliver the 'magic bullet'.
A minimalist but entirely predictable response - the opportunities are in the nuance
December 1, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Pharmac funds and widens access to melanoma medicines
May 11, 2025 - - Latest News -
Non-descript vagueness on pharmaceuticals in US-UK bilateral trade agreement
May 11, 2025 - - Latest News -
Who are 'legislated conditional listings' designed to limit, the industry or the minister?
May 11, 2025 - - Latest News -
Vertex welcomes expanded TGA approval for cystic fibrosis therapy
May 9, 2025 - - Latest News -
Sanofi's consumer health business Opella becomes a standalone company
May 9, 2025 - - Latest News -
New partnership promotes buy local for homegrown innovation
May 8, 2025 - - Latest News -
New Zealand to change laws to promote medical conferences
May 8, 2025 - - Latest News